SecBot SecBot

ASRT

Assertio Holdings, Inc.
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001808665 Biotech & Drug Discovery
—
Median target
$23.50
range $21.80–28.00
Next earnings
Nov 9
in 13 days · EPS est. $0.06
Short interest
156.3K
−53.3%
Days to cover
1.0
at average volume
Insider net
$0
no open-market trades · since Mar 2
New fund stakes
0
Q1 2026 13F · 0 exits
Filing reports
10
analyzed by SecBot
SecBot read MIXED 2 reports · latest
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 1/2 ·Next Earnings date, Nov 9, 2026

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells since Mar 2. Recent filings are awards, exercises and tax withholding.

  • InstitutionsMIXED

    Q1 2026: 4 added (0 new), 2 trimmed or exited.

  • EstimatesFALLING

    Current-quarter EPS estimate $0.400 → $0.060 over 90 days. 0 up, 1 down in 30 days.

  • Short sellersCOVERING

    Short interest −53.3% to 156.3K shares. 1.0 days to cover.

Who's buying

13F· Q1 2026
0
new positions
0
exits
FundMoveSharesValue
JANE STREET GROUP, LLCDOUBLED79,436$1.5M
BANK OF AMERICA CORP /DE/DOUBLED25,033$477.1K
MILLENNIUM MANAGEMENT LLCTRIM16,425$313.1K
UBS Group AGDOUBLED6,331$120.7K
OSAIC HOLDINGS, INC.DOUBLED376$7.2K
FMR LLCTRIM23$438.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action May 2026
Recent actions
DateFirmActionRating
May 13, 2026Lake Street
MAINTAIN
MAINTAINHold
May 5, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINNeutral

Washington

Q3 2026
Lobbying Q3 None last Q4 2024
YoY n/a vs Q3 2025
Members 0 90 days
Buys / sells 0 / 0 0 trades

Insider ledger

Form 4
$0
open-market buys or sells · since Mar 2
DateInsiderTypeValue
Jun 16, 2026
Patel Ajay
EVP and CFO
TENDER15,942 sh
Jun 16, 2026
Patel Ajay
EVP and CFO
TO ISSUER26,026 sh
Jun 16, 2026
Patel Ajay
EVP and CFO
TO ISSUER15,666 sh
Jun 16, 2026
Stark David Matthew
Director
TENDER11,420 sh
Jun 16, 2026
Mason Heather L
Director
TENDER20,944 sh
Jun 16, 2026
Mason Heather L
Director
TO ISSUER36,666 sh
Jun 16, 2026
Stark David Matthew
Director
TO ISSUER5,415 sh
Jun 16, 2026
Reisenauer Mark L
CEO
TENDER3,583 sh

Earnings setup

Estimates
Nov 9
reports in 13 days
$0.06
EPS estimate, this quarter
−85%
estimate change, 90 days
0↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.06$0.06–$0.06+111.5%$34.3M
Next Q$0.73$0.73–$0.73+3.5%$35.8M
Current FY-$1.79-$1.79–-$1.79+43.0%$116.7M
Next FY$0.58$0.05–$1.11+52.6%$126.6M

Short side

FINRA· Jun 15, 2026
156,285
shares short
-53.3%
vs prior settlement
1.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Aug 10, 2026 Earnings calendar
ASRT Q2 2026 Earnings Scheduled — 2026-08-10
Jul 7, 2026 SEC
Nasdaq filed a Form 25-NSE to remove Assertio Holdings' common stock from listing and SEC registration, effective July…
25-NSE — Impact 5/10
Jun 26, 2026 SEC
Assertio Holdings filed a Form 15-12G to terminate its SEC registration, citing only one holder of record. This…
15-12G — Impact 6/10
Jun 18, 2026 SEC
Assertio Holdings, Inc. received SEC effectiveness on June 17, 2026 for four separate shelf registration statements…
EFFECT — Impact 5/10
Jun 16, 2026 Insider
Patel Ajay disposed of 15,942 shares
EVP and CFO
Jun 16, 2026 Insider
Patel Ajay disposed of 26,026 shares
EVP and CFO
Jun 16, 2026 Insider
Patel Ajay disposed of 15,666 shares
EVP and CFO
Mar 31, 2026 Inst.
JANE STREET GROUP, LLC — DOUBLED
79,436 shares ($1.5M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent

SecBot reports

10 filings · 4 bullish · 0 bearish · 6 neutral
All ASRT filing & press-release reports (10)